Oppositional Defiant Disorder | Defiant Teenager | Defiant Kid | ADHD

Back to ADHD News List

Shire Announces Study Results For Investigational Drug SPD465 Designed To Reduce ADHD Symptoms For Up To 16 Hours

Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) announced the results of two phase II trials in adults (studies 201 and 203) of the investigational amphetamine compound SPD465 (triple-bead mixed amphetamine salts [MAS]) at a major medical meeting of child and adolescent psychiatrists in San Diego, Calif. [click link for full article]

Source: http://www.medicalnewstoday.com/sections/adhd/

 

In schools, treatment plans are often poorly integrated. In addition, there are few special education funds directed specifically for ADHD
 

This page is about Attention deficit hyperactivity disorder (ADHD)

Oppositional Defiant Disorder | Defiant Teenager | Defiant Kid | ADHD